World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
37060
World Ranking
8272
National Ranking
4282

Overview

Wendy B. London is affiliated with Harvard University in the United States and has a body of work primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans significant topics in neurology, genetics, oncology, molecular biology, and cancer research.

Their publication record includes numerous papers focused on neuroblastoma as well as broader cancer research topics. Key research topics covered in their work include:

  • Neuroblastoma Research and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Glioma Diagnosis and Treatment
  • Cancer Therapeutics and Mechanisms
  • Lung Cancer Research Studies
  • Neurofibromatosis and Schwannoma Cases
  • Blood Groups and Transfusion

London has frequently published in a set of specific research journals, demonstrating an ongoing engagement with clinical and cancer-related research communities. The most common venues for their publications are:

  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • Blood
  • Transplantation and Cellular Therapy
  • Cancer Medicine

Their list of frequent collaborators includes the following researchers:

  • Pei-Chi Kao
  • Arlene Naranjo
  • Steven G. DuBois
  • Rochelle Bagatell
  • Julie R. Park

Among their recent papers, the following stand out for their focus and publication venues:

  • "Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group," 2021, Journal of Clinical Oncology
  • "Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease," 2020, New England Journal of Medicine
  • "Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032," 2021, Clinical Cancer Research
  • "Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group," 2020, Journal of Clinical Oncology
  • "Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project," 2020, Journal of Clinical Oncology

Best Publications

  • Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    Alice L. Yu;Andrew L. Gilman;M. Fevzi Ozkaynak;Wendy B. London

  • The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

    Susan L. Cohn;Andrew D.J. Pearson;Wendy B. London;Tom Monclair

  • The genetic landscape of high-risk neuroblastoma

    Trevor J Pugh;Olena Morozova;Edward F Attiyeh;Edward F Attiyeh;Shahab Asgharzadeh;Shahab Asgharzadeh

  • The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

    Tom Monclair;Garrett M. Brodeur;Peter F. Ambros;Hervé J. Brisse

  • Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

    Katherine K. Matthay;C. Patrick Reynolds;Robert C. Seeger;Hiroyuki Shimada

  • Activating mutations in ALK provide a therapeutic target in neuroblastoma

    Rani E. George;Takaomi Sanda;Megan C. Hanna;Stefan Fröhling

  • Advances in Risk Classification and Treatment Strategies for Neuroblastoma

    Navin R. Pinto;Mark A. Applebaum;Samuel L. Volchenboum;Katherine K. Matthay

  • Chromosome 1p and 11q deletions and outcome in neuroblastoma.

    Edward F. Attiyeh;Wendy B. London;Yael P. Mossé;Qun Wang

  • Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

    W.B. London;R.P. Castleberry;K.K. Matthay;A.T. Look

  • Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease

    Cameron K. Tebbi;Wendy B. London;Debra Friedman;Doojduen Villaluna

  • Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project

    Hervé J. Brisse;M. Beth McCarville;Claudio Granata;K. Barbara Krug

  • A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency

    Salima Hacein-Bey-Abina;Sung Yun Pai;H. Bobby Gaspar;Myriam Armant

  • International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

    PF Ambros;IM Ambros;GM Brodeur;M Haber

  • Copy number variation at 1q21.1 associated with neuroblastoma

    Sharon J. Diskin;Cuiping Hou;Joseph T. Glessner;Edward F. Attiyeh;Edward F. Attiyeh

  • Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma

    Daniel E. Bauer;Chelsey M. Mitchell;Kelly M. Strait;Christopher S. Lathan

  • Children's Oncology Group's 2013 blueprint for research: Neuroblastoma

    Julie R. Park;Rochelle Bagatell;Wendy B. London;John M. Maris

  • ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma

    Scott C. Bresler;Daniel A. Weiser;Daniel A. Weiser;Peter J. Huwe;Jin H. Park

  • Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

    Mario Capasso;Marcella Devoto;Cuiping Hou;Shahab Asgharzadeh

  • Outcome and Staging Evaluation in Malignant Germ Cell Tumors of the Ovary in Children and Adolescents: An Intergroup Study

    D Billmire;C Vinocur;F Rescorla;B Cushing

  • Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

    David L. Baker;Mary L. Schmidt;Susan L. Cohn;John M. Maris

Frequent Co-Authors

Susan L. Cohn
Susan L. Cohn University of Chicago
John M. Maris
John M. Maris Children's Hospital of Philadelphia
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Michael D. Hogarty
Michael D. Hogarty Children's Hospital of Philadelphia
Robert C. Seeger
Robert C. Seeger Children's Hospital of Los Angeles
Hiroyuki Shimada
Hiroyuki Shimada Stanford University
Peter F. Ambros
Peter F. Ambros St Anna Children's Hospital
Andrew D.J. Pearson
Andrew D.J. Pearson Royal Marsden NHS Foundation Trust
Alice L. Yu
Alice L. Yu University of California, San Diego
Julie M. Gastier-Foster
Julie M. Gastier-Foster Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens up diverse paths beyond a traditional MD. Online degree options have expanded rapidly, making healthcare careers more accessible and flexible for students with busy schedules or those looking for faster, affordable routes.

Pharmacy is a high-demand field, and a 3-year online pharmd enables you to earn a doctorate in pharmacy entirely online, combining convenience with advanced qualification. For those interested in healthcare administration, an online bachelor's in health information management is a smart choice, preparing you for roles managing medical records and data systems in hospitals and clinics.

If you prefer the administrative side, earning a medical coding certification online offers a quick and affordable way to start working in healthcare facilities, insurance companies, or remote positions. Meanwhile, nurses seeking career advancement can enroll in the cheapest online acute care nurse practitioner programs for specialized clinical training and higher earning potential.

Whether you’re interested in direct patient care, administration, or health technology, online degrees offer multiple affordable entry points to a rewarding healthcare career.

Best Scientists Citing Wendy B. London

Trending Scientists

Recently Published Articles